Short review outlines image preparation processes and precision strategies for managing brain metastasis with SIMT-SRS, suggesting improved outcomes.
Single isocenter multiple target stereotactic radiosurgery (SIMT-SRS) has potentially emerged as a new pillar in radio-immune combination therapy for the management of brain metastasis. Accuracy and efficiency are pushed to a higher level in the era of the linear accelerator-based SIMT-SRS. This short review focuses on patient selection, image preparation, patient simulation, electronic portal imaging device (EPID) QA, and the patient treatment process in the SIMT-SRS treatment only. Image-relevant recommendations and guidelines are presented and contrast application, acquisition efficiency, and alignment accuracy of CT and MRI images are explored. With guidance, the SIMT-SRS can be implemented with high precision and efficiency. 1 mm or 0.5 mm and non-uniform PTV margin expansion for all targets would become possible. It will enhance cancer killing effect in radio-immune combination therapy. General routine daily, monthly, and annual linear accelerator image quality assurances are excluded.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: